Sarepta Therapeutics (SRPT) Goodwill & Intangibles (2010 - 2026)

Sarepta Therapeutics' Goodwill & Intangibles history runs 17 years deep, the most recent figure standing at $31.4 million for Q1 2026.

• In Q1 2026, Goodwill & Intangibles rose 19.79% year-over-year to $31.4 million; the TTM figure through Mar 2026 stood at $31.4 million (up 19.79% YoY), while the FY2025 annual figure was $28.9 million, up 7.67% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $31.4 million, up from $28.9 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $31.4 million in Q1 2026, with the low at $7.2 million in Q1 2023.
• The 5-year median for Goodwill & Intangibles is $26.2 million (2025), against an average of $21.2 million.
• The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles sank 46.78% in 2022, then surged 301.86% in 2024.
• Sarepta Therapeutics' Goodwill & Intangibles stood at $7.6 million in 2022, then jumped by 31.96% to $10.0 million in 2023, then surged by 168.87% to $26.9 million in 2024, then advanced by 7.67% to $28.9 million in 2025, then gained by 8.41% to $31.4 million in 2026.
• Business Quant data shows SRPT's Goodwill & Intangibles at $31.4 million in Q1 2026, $28.9 million in Q4 2025, and $29.7 million in Q3 2025.